In this study, we investigated whether the enhancement of glutamate dehydrogenase (GDH) activity, by using the GDH activator 2‐aminobicyclo‐(2,2,1)‐heptane‐2‐carboxylic acid (BCH), has neuroprotective potential against PD injury. The gene discussed is GLUD1; the disease is Parkinson disease.